ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $48,109,000 | -53.3% | 1,038,390 | -75.4% | 1.10% | -62.0% |
| Q1 2019 | $103,101,000 | +15219.6% | 4,228,900 | +10437.2% | 2.91% | +16061.1% |
| Q2 2018 | $673,000 | +2.7% | 40,133 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $655,000 | +187.3% | 40,133 | +57.3% | 0.02% | +38.5% |
| Q1 2017 | $228,000 | -96.8% | 25,510 | -97.8% | 0.01% | -95.6% |
| Q3 2013 | $7,126,000 | +7997.7% | 1,145,740 | +5830.3% | 0.29% | +3155.6% |
| Q2 2013 | $88,000 | – | 19,320 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,224,428 | $281,103,000 | 10.86% |
| BVF INC/IL | 5,062,768 | $82,624,000 | 8.38% |
| First Light Asset Management, LLC | 1,675,148 | $27,338,000 | 6.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 851,500 | $13,888,000 | 5.42% |
| EcoR1 Capital, LLC | 3,049,312 | $49,765,000 | 4.99% |
| X-Square Capital, LLC | 167,338 | $2,731,000 | 2.88% |
| Eversept Partners, LP | 357,727 | $5,838,105 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,031,650 | $16,837,000 | 1.85% |
| Copernicus Capital Management, LLC | 131,418 | $2,145,000 | 1.71% |
| Asymmetry Capital Management, L.P. | 81,649 | $1,333,000 | 1.67% |